The Merck-Moderna cancer trial validation sparked a massive +127% rip on $MRNA today. Retail sees a rocket ship; historical data sees a classic distribution trap.
Across 2,881 historical catalyst-driven gap-ups exceeding 30%, the asset closes red 65% of the time from open with a median intraday fade of -6.79%.
A great headline doesn't rewrite the laws of mean reversion.